TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING BEAUTY CONSCIOUSNESS
2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
2.5.3. TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
3.1.2. RISING CASES OF OBESITY
3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
3.2.2. SIDE EFFECTS POST-TREATMENT
3.2.3. LACK OF AWARENESS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. PRODUCT DEVELOPMENT
4.7.3. MARKETING AND DISTRIBUTION
4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
4.8.1. COST
4.8.2. BRAND REPUTATION
4.8.3. USABILITY
5. MARKET BY PROCEDURE
5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL
6. MARKET BY TYPE
6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.2. CANADA
8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. EUROPE CELLULITE TREATMENT MARKET DRIVERS
8.2.3. EUROPE CELLULITE TREATMENT MARKET CHALLENGES
8.2.4. EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.2.5. KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
8.2.6. COUNTRY ANALYSIS
8.2.6.1. UNITED KINGDOM
8.2.6.1.1. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.2. GERMANY
8.2.6.2.1. GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.3. FRANCE
8.2.6.3.1. FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.4. ITALY
8.2.6.4.1. ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.5. BELGIUM
8.2.6.5.1. BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.6. POLAND
8.2.6.6.1. POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.7. REST OF EUROPE
8.2.6.7.1. REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
8.3.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
8.3.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.3.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
8.3.6. COUNTRY ANALYSIS
8.3.6.1. CHINA
8.3.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.2. JAPAN
8.3.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.3. INDIA
8.3.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.4. SOUTH KOREA
8.3.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.5. THAILAND
8.3.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.6. INDONESIA
8.3.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.7. VIETNAM
8.3.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.8. AUSTRALIA & NEW ZEALAND
8.3.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.9. REST OF ASIA-PACIFIC
8.3.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. REST OF WORLD CELLULITE TREATMENT MARKET DRIVERS
8.4.3. REST OF WORLD CELLULITE TREATMENT MARKET CHALLENGES
8.4.4. REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.4.5. KEY PLAYERS IN REST OF WORLD CELLULITE TREATMENT MARKET
8.4.6. REGIONAL ANALYSIS
8.4.6.1. LATIN AMERICA
8.4.6.1.1. LATIN AMERICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.4.6.2. MIDDLE EAST & AFRICA
8.4.6.2.1. MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBVIE INC
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. FINANCIAL ANALYSIS
9.2.1.3. PRODUCTS / SERVICES LIST
9.2.1.4. STRENGTHS & CHALLENGES
9.2.2. ALMA LASERS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS / SERVICES LIST
9.2.3. BAUSCH HEALTH COMPANIES INC.
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. FINANCIAL ANALYSIS
9.2.3.3. PRODUCTS / SERVICES LIST
9.2.3.4. STRENGTHS & CHALLENGES
9.2.4. CANDELA CORPORATION
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS / SERVICES LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. CUTERA INC
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. FINANCIAL ANALYSIS
9.2.5.3. PRODUCTS / SERVICES LIST
9.2.5.4. STRENGTHS & CHALLENGES
9.2.6. CYNOSURE LLC
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCTS / SERVICES LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. ENDO INTERNATIONAL PLC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. FINANCIAL ANALYSIS
9.2.7.3. PRODUCTS / SERVICES LIST
9.2.7.4. STRENGTHS & CHALLENGES
9.2.8. GALDERMA SA
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCTS / SERVICES LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. INCELER MEDIKAL CO LTD
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCTS / SERVICES LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. JOHNSON & JOHNSON
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. FINANCIAL ANALYSIS
9.2.10.3. PRODUCTS / SERVICES LIST
9.2.10.4. STRENGTHS & CHALLENGES
9.2.11. MERZ PHARMA GMBH & CO KGAA
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCTS / SERVICES LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. NUBWAY CO LTD
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCTS / SERVICES LIST
9.2.13. SIENTRA INC
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. FINANCIAL ANALYSIS
9.2.13.3. PRODUCTS / SERVICES LIST
9.2.13.4. STRENGTHS & CHALLENGES
9.2.14. SINCLAIR PHARMA
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCTS / SERVICES LIST
9.2.15. ZIMMER MEDIZINSYSTEME
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCTS / SERVICES LIST
9.2.15.3. STRENGTHS & CHALLENGES
世界のセルライトトリートメント市場2023-2032 |
| 【英語タイトル】GLOBAL CELLULITE TREATMENT MARKET FORECAST 2023-2032 | |
 | ・商品コード：INK23AP005 ・発行会社（調査会社）：Inkwood Research ・発行日：2023年3月24日 ・ページ数：232 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：消費財 |
| Single User | USD2,500 ⇒換算￥380,000 | 見積依頼/購入/質問フォーム |
| Multi License | USD3,000 ⇒換算￥456,000 | 見積依頼/購入/質問フォーム |
| Enterprisewide Price | USD4,500 ⇒換算￥684,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| Inkwood Research社は、セルライトトリートメントの世界市場規模が2023年から2032年の間で年平均成長率9.44%に及ぶと予測しています。本調査書では、セルライトトリートメントの世界市場ついて調査・分析し、調査範囲・調査方法、エグゼクティブサマリー、市場動向、主要分析、処置別（ソフトセルライト、ハードセルライト、浮腫性セルライト）分析、エンドユーザー別（病院、診療所・美容院、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、その他）分析、競争状況などをまとめています。また、こちらの調査書には、ABBVIE INC、ALMA LASERS、BAUSCH HEALTH COMPANIES INC、CANDELA CORPORATION、CUTERA INC、CYNOSURE LLC、ENDO INTERNATIONAL PLC、GALDERMA SA 、INCELER MEDIKAL CO LTD、JOHNSON & JOHNSON などの企業情報が含まれています。 ・調査範囲・調査方法 ・エグゼクティブサマリー ・市場動向 ・主要分析 ・世界のセルライトトリートメント市場規模：処置別 - ソフトセルライトにおける市場規模 - ハードセルライトにおける市場規模 - 浮腫性セルライトにおける市場規模 ・世界のセルライトトリートメント市場規模：エンドユーザー別 - 病院における市場規模 - 診療所・美容院における市場規模 - その他エンドユーザーにおける市場規模 ・世界のセルライトトリートメント市場規模：地域別 - 北米のセルライトトリートメント市場規模 - ヨーロッパのセルライトトリートメント市場規模 - アジア太平洋のセルライトトリートメント市場規模 - その他地域のセルライトトリートメント市場規模 ・競争状況 |
KEY FINDINGS
The global cellulite treatment market is anticipated to register a CAGR of 9.44% during the forecast period 2023-2032. Some of the key drivers facilitating the market’s growth include the increasing demand for aesthetic and cosmetic procedures, rising cases of obesity, as well as the rapidly booming medical tourism industry.
MARKET INSIGHTS
Cellulite is characterized as fat collections that push against the connective tissue beneath the skin. It appears on the stomach, buttocks, and thighs. Cellulite may be caused due to accumulated toxins, poor diet, genetics, pregnancy, weight gain, and inactivity.
Obesity is one of the leading health concerns globally. Obesity leads to cellulite by virtue of heightening the volume of fat trapped within irregular-sized fat lobules. According to the Centers for Disease Control and Prevention (CDC), obesity prevalence in the United States was more than 41% in 2017. Furthermore, according to the World Health Organization (WHO), approximately 39 million children under the age of 5 were obese or overweight in the year 2020. People with obesity are more vulnerable to health issues like cardiac disorders, diabetes, high blood pressure, strokes, and other conditions. Such health problems encourage individuals to undergo treatment for obesity, thereby facilitating the global cellulite treatment market growth.
REGIONAL INSIGHTS
The global cellulite treatment market growth analysis covers a detailed assessment of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is set to grow with the highest CAGR during the forecast period. The regional market’s growth is primarily ascribed to the presence of skilled professionals and high-quality healthcare facilities, in addition to the lower cost of treatments and premium healthcare services.
COMPETITIVE INSIGHTS
The degree of industrial rivalry within the global cellulite treatment market is projected to be high during the forecast period. Some of the key companies operating in the market are Johnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
❖ レポートの目次 ❖
| ★調査レポート[世界のセルライトトリートメント市場2023-2032] (コード：INK23AP005)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のセルライトトリートメント市場2023-2032]についてメールでお問い合わせ |
